Co-Authors
This is a "connection" page, showing publications co-authored by Stephen Eeden and Sheila Weinmann.
Connection Strength
0.955
-
Association of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8(4):e374-81.
Score: 0.228
-
Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate. 2013 Sep; 73(13):1371-7.
Score: 0.224
-
The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship. BMC Cancer. 2022 Feb 25; 22(1):209.
Score: 0.103
-
Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control. 2010 Jan; 21(1):117-25.
Score: 0.087
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.080
-
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 05 01; 115(18):E4179-E4188.
Score: 0.078
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.071
-
Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology. 2005 May; 16(3):367-76.
Score: 0.064
-
Racial differences in treatment of early-stage prostate cancer. Urology. 2008 Jun; 71(6):1172-6.
Score: 0.019